Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623100 · ClinicalTrials.gov registry record · NA
Neural Indices of Intervention Outcomes in Children With Speech Sound Disorders
A NA study of Speech Sound Disorder, sponsored by Idaho State University.
- Active
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT03623100: Active NA study of Speech Sound Disorder, sponsored by Idaho State University.
NCT03623100 is a NA study of Speech Sound Disorder that is active but no longer recruiting, run by Idaho State University. The registered enrollment target is 42 participants, below the 86-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03623100, a NA study of Speech Sound Disorder, is active but no longer recruiting, sponsored by Idaho State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Children with speech sound disorders (SSD) are thought to be unable to detect subtle differences between sounds, though there is little understanding of the underlying perceptual mechanisms implicated in SSD. The investigators suggest that children with SSD may have difficulty creating phonological representations due to inaccurate perception and representation of speech sounds, which then directly impacts speech production abilities. Children will be randomly assigned to one of two treatment conditions in the present study: 1) Traditional speech treatment alone or 2) Traditional speech treatment in conjunction with speech perceptual training. By identifying an underlying mechanism of the disorder, the clinical approach to the treatment of SSD will be better informed and treatment approaches targeting all deficient areas can be utilized.
Primary Outcome
Each treated sound will be point-by-point identified as being correct or incorrect in relation to its target phoneme. From these values, generalization data from each child will be examined from both descriptive and quantitative perspectives. Generalization will be descriptively defined using the learning criterion level of 10% or greater accuracy change in treated phonemes (Gierut \& Morrisette, 2012a). For each child and each condition, generalization will be examined to see if the 10% criteri
Conditions Studied
Interventions
- BEHAVIORAL Speech Production Treatment.
- BEHAVIORAL Speech Production + Speech Perception Treatment.
Study Locations (1)
Idaho
- Idaho State University - Meridian - Meridian
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT03623100 still lists
NCT03623100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 86-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which Speech Production Treatment. is the first listed.
NCT03623100 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT03623100 about?
NCT03623100 is a clinical study titled "Neural Indices of Intervention Outcomes in Children With Speech Sound Disorders". Children with speech sound disorders (SSD) are thought to be unable to detect subtle differences between sounds, though there is little understanding of the underlying perceptual mechanisms implicated in SSD. The investigators suggest that children with SSD may have difficulty creating phonological ...
What is the current status of trial NCT03623100?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2014-08-01. Estimated completion is 2026-07-31.
What conditions does trial NCT03623100 study?
This clinical trial studies the following conditions: Speech Sound Disorder.
What interventions are being tested in trial NCT03623100?
The interventions under investigation include: Speech Production Treatment. (BEHAVIORAL), Speech Production + Speech Perception Treatment. (BEHAVIORAL).
Who is sponsoring clinical trial NCT03623100?
This trial is sponsored by Idaho State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03623100 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Sound Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03623100's enrollment target sits among peer trials
42 10th of 15 higher than 6 of 15 other Speech Sound Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simplified Ultrasound Feedback for Speech Remediation
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
RECRUITING · NA
-
Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics
RECRUITING · NA
-
Measuring Aided Language Development
RECRUITING · NA
-
BiOfeedback, Online for Sibilant Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI